Home › NDC Lookup › RxCUI directory › RxCUI 861824

Metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met] — RxCUI 861824

RxNorm drug concept · Semantic branded drug
RxCUI 861824 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861824
Official nameMetformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asActoplus Met 15/850 MG Oral Tablet; actoplus met 15 MG / 850 MG Oral Tablet; Actoplus Met 15/850 (metformin hydrochloride 850 MG / pioglitazone (as pioglitazone hydrochloride) 15 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Metformin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Metformin works in three ways: it lowers the amount of sugar your liver dumps into your bloodstream, slows how much sugar your gut absorbs from food, and helps your body respond to...
  • What exactly is metformin doing for my diabetes?
  • Yes, this is very common — diarrhea, nausea, and stomach discomfort are the most frequently reported side effects, and they're often worst when you first start or when your dose go...
  • My stomach has been a mess since I started metformin. Is that normal? Will it get better?
📖 Read our full Metformin guide →

🕸️ Concept Web — How Metformin hydrochloride 850 MG / pioglitazone 15... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet [Actoplus Met] RxCUI 861824

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Metformin 6809
    • Pioglitazone 33738
    • Metformin / pioglitazone 607999
    • Metformin hydrochloride 235743
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Actoplus Met 602411
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Metformin / pioglitazone Oral Tablet 577093
    • Metformin hydrochloride / pioglitazone Oral Tablet 2647189
    • Metformin / pioglitazone Oral Product 1161597
    • Metformin / pioglitazone Pill 1161598
    • Metformin hydrochloride / pioglitazone Oral Product 2661623
    • Metformin hydrochloride / pioglitazone Pill 2659523
    • Metformin / pioglitazone Oral Tablet [Actoplus Met] 731442
    • Metformin hydrochloride / pioglitazone Oral Tablet [Actoplus Met] 2655947
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet SCD · 861822
  • Metformin hydrochloride 850 MG SCDC · 861009
  • Pioglitazone 15 MG SCDC · 332435
  • Metformin / pioglitazone Oral Tablet SCDF · 577093
  • Metformin hydrochloride / pioglitazone Oral Tablet SCDFP · 2647189
  • Metformin / pioglitazone Oral Product SCDG · 1161597
  • Metformin / pioglitazone Pill SCDG · 1161598
  • Metformin hydrochloride / pioglitazone Oral Product SCDGP · 2661623
  • Metformin hydrochloride / pioglitazone Pill SCDGP · 2659523

Brand-Name Concepts

  • Metformin hydrochloride 850 MG / pioglitazone 15 MG [Actoplus Met] SBDC · 861823
  • Metformin / pioglitazone Oral Tablet [Actoplus Met] SBDF · 731442
  • Metformin hydrochloride / pioglitazone Oral Tablet [Actoplus Met] SBDFP · 2655947
  • Actoplus Met Oral Product SBDG · 1169920
  • Actoplus Met Pill SBDG · 1169923
  • Actoplus Met BN · 602411

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 861824 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64764-0158-18 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-158-18) Actoplus Met Takeda Pharmaceuticals America, Inc. 2005-08-29
64764-0158-41 4 CARTON in 1 TRAY (64764-158-41) / 1 BLISTER PACK in 1 CAR... Actoplus Met Takeda Pharmaceuticals America, Inc. 2005-08-29
64764-0158-60 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64764-158-60) Actoplus Met Takeda Pharmaceuticals America, Inc. 2005-08-29
Observed labelers: Takeda Pharmaceuticals America, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.